More importantly, due to the lack of an isogenic “disease-free” control iPSC line, it is hard to determine whether the phenotypic differences are caused by ERCC6 gene mutations or genetic background variations between CS patients and control individuals. This evidence concerns the gene ERCC6 and Cowden syndrome 1.